ABUS 股东权益历史(2016–2025)
Arbutus Biopharma Corp (ABUS) 各财年年末股东权益(来自 SEC 财报)。
$76.6MFY2025 · FY2016 以来:$203.0M → $76.6M
| 财年 | 数值 | 同比 |
|---|---|---|
| FY2025 | $76.6M | -21.4% |
| FY2024 | $97.4M | -8.2% |
| FY2023 | $106.0M | -22.5% |
| FY2022 | $136.9M | -19.2% |
| FY2021 | $169.4M | +66.2% |
| FY2020 | $102.0M | +40.2% |
| FY2019 | $72.7M | -63.7% |
| FY2018 | $200.2M | +9.7% |
| FY2017 | $182.5M | -10.1% |
| FY2016 | $203.0M | — |
数据来自 SEC XBRL 申报 · 仅供参考 · 非投资建议